Encouraging Signs that the Insulin Affordability Battle is Improving This week, as congressional hearings focus on access to affordable insulins, it should be recognized that a multitude of market forces are working to reduce the cost of insulin products for
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement regarding a white paper released today by the American Diabetes Association on insulin prices: “The American Diabetes Association’s new white paper on insulin prices confirms that drugmakers set, and
(Washington, D.C.) — In honor of World Diabetes Day, the Pharmaceutical Care Management Association (PCMA) has launched a new phase of the OnYourRxSide campaign that showcases how pharmacy benefit managers, PBMs, are working to improve the lives of patients living
Medium: Pharmacy Benefit Managers – Providing Lower Prescription Costs for State Medicaid Programs Dealing with COVID-19 June 5, 2020 Given this growing challenge, pharmacy benefit managers (PBMs) have never been more essential. For both public programs and private insurance, PBMs
(Washington, D.C.) – As independent drugstore lobbyists descend on Albany for their special interest lobby day, the Pharmaceutical Care Management Association (PCMA) released the following statement: “Pharmacy benefit managers (PBMs) advocate on behalf of New York’s consumers and health plan sponsors by negotiating
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the eve of Governor Andrew Cuomo’s 2020 State of the State Address and the start of the state legislative session in Albany:
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing new staff additions to the Federal Affairs, State Affairs, Strategic Communications, and Industry Relations departments. “I want to welcome Jocelyn Wiles, Heather Cascone, Mike Baldyga, and Kayla Firriolo to PCMA’s
Economic Analyses Shows “Delinking” Policy Hands Big Pharma a Financial Windfall totaling $32 Billion Annually (Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) issued the following statement on the introduction of H.R. 6283, “Delinking Revenue from Unfair Gouging Act” or
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide. The campaign is designed
©2024 PCMA. All Rights Reserved.
